Complementary botanical raw materials engineered for neuro-calm, adaptogenic, and hepatoprotective formulations. Full analytical release dossiers accompany every lot.
A rigorous B2B procurement briefing for nutraceutical formulators, contract research organisations (CROs), and compliance executives sourcing Valeriana officinalis globally.
Valerian root's therapeutic value is historically attributed to its volatile sesquiterpenoids, principally valerenic acid, hydroxyvalerenic acid, and acetoxyvalerenic acid. Qualified manufacturers utilise High-Performance Liquid Chromatography (HPLC-DAD) to quantitate total valerenic acids.
Commercial grades typically standardise between 0.4% and 0.8% valerenic acid. Reliable exporters eliminate degradation risks caused by thermal stress during hydroalcoholic extraction and spray-drying phases.
The pungent, isovaleric odor profile inherent to valerian biomass presents manufacturing obstacles in finished solid-dose forms. Premier processing plants leverage dedicated low-temperature vacuum drying, cyclodextrin microencapsulation, or proprietary carrier adsorption to mask sensory notes.
Extraction ratios typically span from 4:1 native extract up to 10:1 concentration indexes, demanding strict residual solvent limits verified under USP <467> Class 2 and Class 3 guidelines.
Supplying multinational brands requires cross-compliance across USP (United States Pharmacopeia), Ph. Eur. (European Pharmacopoeia), and BP specifications. Key verification benchmarks include heavy metals by ICP-MS (Pb ≤ 0.5 ppm, As ≤ 0.5 ppm, Cd ≤ 0.2 ppm, Hg ≤ 0.1 ppm).
Exporters must also furnish real-time stability dossiers, pesticide screening covering over 400 compounds via LC-MS/MS, and irradiation-free bio-burden validation.
| Extract Type / Ratio | Marker Specification | Analytical Technique | Key Dosage Forms | Lead Documentation Required |
|---|---|---|---|---|
| Standardised Hydroalcoholic (0.8%) | Total Valerenic Acids ≥ 0.8% | HPLC-UV / DAD (Ph. Eur.) | Hard Capsules, Two-Piece Softgels | CoA, TLC Fingerprint, Residual Solvents |
| Standardised Native Extract (0.4%) | Valerenic Acid ≥ 0.42% | HPLC (USP Method) | Tablets, Sleep Blends, Sachets | Heavy Metals ICP-MS, Pesticide Screen |
| Concentrated Ratio Extract (10:1) | Extract Ratio 10:1 (Native ∼ 25%) | TLC / Marker Presence | Herbal Infusions, Effervescents | Microbial Assay, ETO & Irradiation Free |
| Microencapsulated Odor-Masked | Standardised Valerenic 0.3% - 0.5% | GC-MS & HPLC | Gummies, Functional RTD Beverages | Particle Size (80 Mesh), Dissolution Test |
Market intelligence forecast for industrial buyers, procurement directors, and supplement formulators navigating 2025–2030 supply challenges.
Regulatory authorities in the UK and European Union (EFSA) are escalating scrutiny on hydrocarbon residues. Global extract manufacturers are shifting rapidly towards water-only or bio-fermented ethanol extraction protocols.
Procurement directors increasingly mandate verified low-residual COA documentation, eliminating non-polar petrochemical carriers entirely while safeguarding delicate ester bounds within the valepotriate family.
The traditional dietary supplement delivery matrix is undergoing substantial disruption. Sleep-support gummies and functional beverage shots are outpacing conventional two-piece hard capsules in double-digit annual growth rates.
Consequently, the demand for deodorised and taste-masked Valerian Root Extract is surging. Sourcing teams prioritize exporters equipped with nitrogen-purged spray drying and beta-cyclodextrin encapsulation capabilities that eliminate volatile isovaleric acid odor without decreasing active terpene concentrations.
Species adulteration (e.g., substituting authentic Valeriana officinalis with Indian Valerian Valeriana wallichii / jatamansi) represents a persistent liability in bulk markets due to disparities in valepotriate-to-valerenic ratios and potential cytotoxicity concerns.
Leading pharmaceutical buyers now require botanical DNA barcoding and GAP-certified wildcraft cultivation tracking from the farm gate to final packaging, guaranteeing precise botanical origin identification.
Eliminating QA bottlenecks, mitigating supply disruption, and accelerating regulatory clearance across international ports.
Headquartered in England with responsive, same-time-zone communication. We provide seamless compliance files satisfying MHRA, EFSA, and FDA standards from day one.
Zero delivery surprises. Every shipment includes batch-specific HPLC chromatograms, heavy metals (ICP-MS), residual solvents, pesticide panels, and non-GMO statements.
Manufactured under verified GMP and ISO management systems, with fully audited Halal and Kosher certified options available to service international demographics.
Exporting to over 50 countries worldwide. Predictable lead times, temperature-regulated handling, and clear Incoterms (FOB, CIF, DDP) to maintain consistent production cycles.
Direct technical answers addressing the critical evaluation criteria required by vendor qualification teams.
We primarily standardise on Total Valerenic Acids (valerenic acid, acetoxyvalerenic acid, and hydroxyvalerenic acid) quantified via HPLC-DAD at 220 nm according to European Pharmacopoeia (Ph. Eur.) and USP standards. Typical specifications range between 0.4% and 0.8%.
Our raw material intake employs orthogonal testing protocols: macroscopic botanic inspection, high-performance thin-layer chromatography (HPTLC) fingerprint comparison against authenticated reference materials, and targeted DNA sequence confirmation to rule out Valeriana wallichii adulteration.
Each container is delivered with an authentic Certificate of Analysis (CoA), full allergen declaration, irradiation/ETO-free validation, non-GMO attestation, safety data sheet (SDS), and analytical testing reports covering heavy metals, residual solvents, and broad-spectrum pesticide multi-residues.
Yes. We offer micro-milled options (80–120 mesh) designed for high-speed automated encapsulation and compressed tableting, as well as specialised microencapsulated grades intended for functional gummies and powdered drink formulations with significantly subdued aromatic pungency.
Qualified enterprise clients can access comprehensive vendor audit packs, third-party certification credentials (GMP, ISO, Halal, Kosher), and historical batch data. On-site and remote technical audits can be coordinated through our UK technical management desk.
Commercial packaging consists of pharmaceutical-grade 25 kg fiber drums lined with double-layer heat-sealed polyethylene food-grade barrier bags. Our minimum order quantity (MOQ) begins at 25 kg for commercial pilot batches, with scalable multi-ton contract options.
Review comprehensive technical specifications, batch release data sheets, stability test summaries, and certified reference samples with our UK-directed global sourcing team.
